Ken, Announcement of submission of BLA was post
Post# of 148050
Announcement of submission of BLA was posted April 27, 2020.
Subsequent PR from May 11 noted submission of all remaining parts of BLA (data missing from original submission)
Quote:
CytoDyn Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients
https://www.cytodyn.com/investors/news-events...pplication
Quote:
CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020
https://www.cytodyn.com/investors/news-events...g-parts-of